Connect with us

Business

U.S. gives Johnson & Johnson’s COVID-19 vaccine a timeout

Published

on

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

The third coronavirus vaccine authorized for emergency use in the United States is going to sit in the corner by itself for a little while. On Tuesday morning, the Centers for Disease Control and Prevention and the Food and Drug Administration issued a joint statement regarding Johnson & Johnson‘s (NYSE: JNJ) COVID-19 vaccine.

The agencies recommended that health care providers pause their use of Johnson & Johnson’s vaccine until an advisory committee can review six cases in which inoculations were followed by dangerous blood clots. All six occurred in women between the ages of 18 and 48 years old. Most importantly, they…



Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Why the MotorCycle Holdings (ASX:MTO) share price is on watch
Article feature image
Wall Street veterans using old tricks in $3.1 trillion crypto jungle – Sydney Morning Herald